New compound shows hope for prostate cancer therapy

New compound shows hope for prostate cancer therapy

New York, Aug 9 (IANS) Researchers have identified a novel compound that can block testosterone from fuelling the tumours in mice and act as a new generation therapy for prostate cancer.

“Prostate cancer is the most prevalent form of cancer in men, and the principal driver of tumour growth is the androgen receptor,” said John D. Norris, Associate Professor at Duke University in North Carolina, US.

The new compound, called tetraaryl cyclobutane, or CB, is being studied as an option for prostate tumours that have grown resistant to current anti-androgen drugs, notably enzalutamide.

“Suppression of androgen receptor function by anti-endocrine therapies is initially effective, but most tumours develop resistance, resulting in a more aggressive cancer,” Norris added.

The new compound act as competitive inhibitors of androgen receptors, but are structurally different from current anti-androgens such as enzalutamide.

One of the CB compounds, inhibits mutant forms of the androgen receptors that promote resistance to enzalutamide.

It functions by preventing the androgen receptor from entering the nucleus of the cell where it can promote tumour growth.

“It’s encouraging that this compound has a different mechanism of action when compared to current therapies, which gives it a good chance of having efficacy in resistant disease,” Norris said.

Animal models have showed that the compound is active against prostate tumours where enzalutamide fails, the researchers concluded in the paper published online in the journal Nature Chemical Biology.

Leave a Reply

Please enter your comment!

The opinions, views, and thoughts expressed by the readers and those providing comments are theirs alone and do not reflect the opinions of or any employee thereof. is not responsible for the accuracy of any of the information supplied by the readers. Responsibility for the content of comments belongs to the commenter alone.  

We request the readers to refrain from posting defamatory, inflammatory comments and not indulge in personal attacks. However, it is obligatory on the part of to provide the IP address and other details of senders of such comments to the concerned authorities upon their request.

Hence we request all our readers to help us to delete comments that do not follow these guidelines by informing us at Lets work together to keep the comments clean and worthful, thereby make a difference in the community.

Please enter your name here